AMGN
Price
$279.22
Change
-$7.59 (-2.65%)
Updated
Sep 24 closing price
Capitalization
150.32B
34 days until earnings call
GILD
Price
$113.67
Change
-$0.73 (-0.64%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
141.95B
29 days until earnings call
Interact to see
Advertisement

AMGN vs GILD

Header iconAMGN vs GILD Comparison
Open Charts AMGN vs GILDBanner chart's image
Amgen
Price$279.22
Change-$7.59 (-2.65%)
Volume$2.37M
Capitalization150.32B
Gilead Sciences
Price$113.67
Change-$0.73 (-0.64%)
Volume$118.09K
Capitalization141.95B
AMGN vs GILD Comparison Chart in %
Loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGN vs. GILD commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and GILD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (AMGN: $286.81 vs. GILD: $114.40)
Brand notoriety: AMGN and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 106% vs. GILD: 113%
Market capitalization -- AMGN: $154.41B vs. GILD: $141.95B
AMGN [@Pharmaceuticals: Major] is valued at $154.41B. GILD’s [@Pharmaceuticals: Major] market capitalization is $141.95B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $669.64B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 2 FA rating(s) are green whileGILD’s FA Score has 3 green FA rating(s).

  • AMGN’s FA Score: 2 green, 3 red.
  • GILD’s FA Score: 3 green, 2 red.
According to our system of comparison, GILD is a better buy in the long-term than AMGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 4 TA indicator(s) are bullish while GILD’s TA Score has 3 bullish TA indicator(s).

  • AMGN’s TA Score: 4 bullish, 5 bearish.
  • GILD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than GILD.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +5.03% price change this week, while GILD (@Pharmaceuticals: Major) price change was +3.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.08%. For the same industry, the average monthly price growth was +0.15%, and the average quarterly price growth was +13.52%.

Reported Earning Dates

AMGN is expected to report earnings on Oct 29, 2025.

GILD is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.08% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGN($150B) has a higher market cap than GILD($142B). AMGN (22.83) and GILD (22.70) have similar P/E ratio . GILD YTD gains are higher at: 26.477 vs. AMGN (9.832). GILD has less debt than AMGN: GILD (24.9B) vs AMGN (56.2B).
AMGNGILDAMGN / GILD
Capitalization150B142B106%
EBITDA15.9BN/A-
Gain YTD9.83226.47737%
P/E Ratio22.8322.70101%
Revenue34.9BN/A-
Total Cash8.03BN/A-
Total Debt56.2B24.9B226%
FUNDAMENTALS RATINGS
AMGN vs GILD: Fundamental Ratings
AMGN
GILD
OUTLOOK RATING
1..100
6970
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
4512
SMR RATING
1..100
1429
PRICE GROWTH RATING
1..100
6050
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (15) in the Biotechnology industry is in the same range as GILD (15). This means that AMGN’s stock grew similarly to GILD’s over the last 12 months.

GILD's Profit vs Risk Rating (12) in the Biotechnology industry is somewhat better than the same rating for AMGN (45). This means that GILD’s stock grew somewhat faster than AMGN’s over the last 12 months.

AMGN's SMR Rating (14) in the Biotechnology industry is in the same range as GILD (29). This means that AMGN’s stock grew similarly to GILD’s over the last 12 months.

GILD's Price Growth Rating (50) in the Biotechnology industry is in the same range as AMGN (60). This means that GILD’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as GILD (100). This means that AMGN’s stock grew similarly to GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNGILD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
36%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
43%
Advances
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 6 days ago
60%
Declines
ODDS (%)
Bearish Trend 9 days ago
53%
Bearish Trend 9 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
42%
Aroon
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT7.610.21
+2.84%
4D Molecular Therapeutics
GAP22.860.25
+1.11%
Gap Inc (The)
TECTP10.79N/A
N/A
Tectonic Financial
VERA25.96-0.15
-0.57%
Vera Therapeutics
SPCB12.54-0.24
-1.88%
SuperCom Ltd

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with ABBV. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then ABBV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-2.65%
ABBV - AMGN
53%
Loosely correlated
-1.18%
NVS - AMGN
51%
Loosely correlated
+0.15%
BIIB - AMGN
49%
Loosely correlated
-1.18%
PFE - AMGN
47%
Loosely correlated
-0.17%
MRK - AMGN
46%
Loosely correlated
-0.36%
More

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with BMY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+1.70%
BMY - GILD
48%
Loosely correlated
-0.16%
GSK - GILD
45%
Loosely correlated
-0.95%
BIIB - GILD
42%
Loosely correlated
-0.96%
NVS - GILD
42%
Loosely correlated
-0.44%
AMGN - GILD
41%
Loosely correlated
+0.28%
More